Clinical Trial

K-HEALTH in AIR - Barcelona Pilot - Cohort

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study protocol is part of the European (EU) project "Knowledge for improving indoor AIR quality and HEALTH" (K-HEALTHinAIR, 2022-2026 - registry 101057693), which focuses on enhancing our understanding of how poor indoor air quality (IAQ) affects human health. Specifically, the project aims to identify IAQ determinants of adverse health events and to explore the development of cost-effective strategies for the precise monitoring and improvement, of IAQ across Europe. With the current study protocol, the Barcelona Pilot, at the Integrated Health District of Barcelona-Esquerra (AISBE, 520 k citizens), is conducting a cohort study over a two-year period (January 2024 to December 2025) to explore the relationships between IAQ (assessment of chemical pollutants in patients' homes) and health status (acute episodes) in multimorbid patients with chronic respiratory diseases (asthma and Chronic Obstructive Pulmonary Disease - COPD) over a two-year period. The protocol investigates the effectiveness of customized interventions across four critical areas: i) Advanced lung function testing, ii) Continuous IAQ monitoring, iii) Advanced digital support to innovative clinical processes, and iv) Predictive modeling for early identification and management of exacerbations. The ultimate objective is to design and evaluate an innovative integrated care service aiming at enhancing both IAQ and the management of multimorbid patients with chronic obstructive respiratory diseases, with focus on COPD and severe asthma.
Trial Details
NCT Number NCT06421402
Lead Sponsor Institut d'Investigacions Biomèdiques August Pi i Sunyer
Collaborators: Hospital Clinic of Barcelona
Conditions Severe Asthma, COPD
Enrollment 200 participants
Start Date 2023-10-13
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-20